Skip to main content

Advertisement

Open Peer Review Reports for: FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
15 Feb 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
Author responded Author comments
Resubmission - Version 8
Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
Author responded Author comments
Resubmission - Version 10
Submitted Manuscript version 10
Author responded Author comments
Resubmission - Version 11
Submitted Manuscript version 11
Author responded Author comments
Resubmission - Version 12
Submitted Manuscript version 12
Author responded Author comments
Resubmission - Version 13
Submitted Manuscript version 13
Author responded Author comments
Resubmission - Version 14
Submitted Manuscript version 14
Publishing
28 Jan 2016 Editorially accepted
8 Feb 2016 Article published 10.1186/s12885-016-2097-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement